Duloxetine Hydrochloride
Product Images NDC 50090-3317

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 50090-3317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A line graph depicting the proportion of patients with relapse over time (days) from randomization. The graph compares two treatments: placebo and duloxetine. The x-axis represents time in days, ranging from 0 to 250, and the y-axis shows the proportion of patients with relapse from 0.0 to 1.0. The graph illustrates relapse rates for placebo and duloxetine groups over approximately 175 days.*

FDA Label Image

Figure2.jpg (Figure2)

A Kaplan-Meier curve chart illustrating the proportion of patients with relapse over time in days from randomization, comparing Duloxetine treatment and placebo. The chart shows two lines: a solid line for Duloxetine and a dashed line for placebo, indicating relapse proportions over approximately 270 days.*

FDA Label Image

Figure3.jpg (Figure3)

A line graph depicting the percent of patients improved in relation to percent improvement in pain from baseline. The graph compares four groups: Duloxetine 60mg BID, Duloxetine 60mg QD, Duloxetine 20mg QD, and placebo. Each group is represented by distinct markers, showing a trend of decreasing patient improvement as the percent improvement in pain increases.*

FDA Label Image

Figure4.jpg (Figure4)

A line graph showing the percent of patients improved versus percent improvement in pain from baseline for Duloxetine 60mg BID, Duloxetine 60mg QD, and placebo. The graph compares the effectiveness of the two Duloxetine dosing regimens and placebo in pain improvement among patients.*

FDA Label Image

Figure5.jpg (Figure5)

A line graph comparing the percent of patients improved in pain from baseline between a placebo group and a group taking Duloxetine 60/120 mg once daily. The x-axis represents percent improvement in pain from baseline, and the y-axis shows the percent of patients improved. The graph includes data points for both treatment arms across various levels of pain improvement.*

FDA Label Image

Figure6.jpg (Figure6)

A line graph comparing percent of patients improved versus percent improvement in pain from baseline (BOCF) for Duloxetine Hydrochloride 60 mg once daily and placebo. The horizontal axis shows percent improvement in pain, and the vertical axis shows percent of patients improved. Duloxetine shows consistently higher patient improvement across the spectrum than placebo.*

FDA Label Image

Figure7.jpg (Figure7)

A line graph comparing the percent of patients improved versus percent improvement in pain from baseline (BOCF) for Duloxetine 60/120 mg once daily and placebo. The graph shows two lines, with Duloxetine consistently having a higher percentage of patients improved across varying levels of pain improvement.*

FDA Label Image

Dulostructure (Dulostructure)

Chemical structure diagram showing the molecular structure of duloxetine hydrochloride, featuring a naphthalene ring connected to a thiophene ring through a chiral carbon, with additional amino and methyl groups and hydrochloride indicated.*

FDA Label Image

Label Image (Lbl500903317)

Duloxetine Hydrochloride 30 MG capsules label from A-S Medication Solutions, NDC 50090-3317-0. The label indicates each capsule contains Duloxetine Hydrochloride USP equivalent to 30 mg Duloxetine. Storage instructions specify 68 to 77 degrees Fahrenheit. The package contains 33 delay-release capsules as a unit dose. Additional details include a lot number, barcode, and distributor information for A-S Medication Solutions, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.